Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde
| Brand name | AMINOCAPROIC ACID |
| Generic name | AMINOCAPROIC ACID |
| Active ingredient(s) | AMINOCAPROIC ACID |
| Distributed by / for | American Regent, Inc. |
| NDC | 0517-9120-01 |
| Full product label | AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL (5 g/20 mL), packaged in a) 20 mL MULTIPLE DOSE VIAL FOR IV INFUSION (NDC 0517-9120-01), and b) 25x20 mL MULTIPLE DOSE VIALS (NDC 0517-9120-25), Rx Only, American Regent, Inc., Shirley, NY 11967. |
| Recalling firm | American Regent, Inc. |
| Distribution | Nationwide within the U.S |
| Quantity | 63,200 vials |
| Recall initiated | 2026-07-24 |
| Report date | 2026-08-26 |
| Recall completed | — |
| Recall number | D-0794-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Shirley NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗